Le Lézard
Classified in: Health
Subject: TDS

Two Day REACH and RoHS Compliance Seminar: Protecting Revenues with Advanced Compliance (San Francisco, CA, United States - December 6-7, 2018)


DUBLIN, Sept. 17, 2018 /PRNewswire/ --

The "REACH and RoHS Compliance: Protecting Revenues with Advanced Compliance" conference has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

REACH, RoHS, and WEEE all present compliance challenges for companies looking to act in accordance with the laws and directives. This seminar will review the basic fundamentals of each regulation and provide a step by step process for building internal compliance programs.

This 2 day seminar will go into the specifics of the REACH and RoHS regulations, provide case studies and share lessons learned so your organization can benefit from the mistakes of others. We will review the latest on both directives and will draw out key developments and key dates (if applicable) with particular emphasis on requirements for US firms.

Industry standards, third party software, and manual data collection methods will be discussed and a review of part sourcing from distributors, forecasting end of life parts, and managing the bill of material will be included. Attendees will be able to identify risks in their products and supply chains by understanding the impact each regulation has on business and by understanding how and when they need to comply. Students will walk away with a template for the 10 steps to building solid compliance programs.

Learning Objectives:

After completing this seminar, you will gain a better understanding of:

Areas Covered:

Who Should Attend:

For more information about this conference visit

https://www.researchandmarkets.com/research/659hzm/two_day_reach_and?w=5

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 17:05
Antibe Therapeutics Inc. ("Antibe" or the "Company") announced that the Toronto Stock Exchange ("TSX") is reviewing the eligibility for continued listing on the TSX of the securities of the Company. The TSX has identified the Company's financial...

at 16:30
Viatris Inc.  will report its first quarter 2024 financial results on Thursday, May 9, 2024, before the open of the U.S. financial markets. Chief Executive Officer Scott A. Smith and other Company executives will host a webcast at 8:30 a.m. ET on the...

at 16:30
WELL Health Clinic Network Inc. ("WELL"), a subsidiary of WELL Health Technologies Corp. , a digital healthcare company focused on...

at 16:25
Precision BioSciences, Inc. , an advanced gene editing company, today announced the anticipated return of three programs from Prevail Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company. Precision exercised its option to regain...

at 16:25
AIDS Healthcare Foundation (AHF), the world's largest HIV/AIDS organization, is calling on public health officials to provide more education and prevention services around vaccinations as a new measles outbreak spreads through 17 U.S. states. As of...

at 16:19
Community research provider EmVenio Research and Prime Healthcare, an award-winning national health system, today announce their partnership to launch the EmVenio Research Center at Prime Healthcare. The partnership allows EmVenio to conduct research...



News published on and distributed by: